Targeted therapy for renal cell carcinoma: The next lap

Advances in rationally targeted therapeutics over the last decade have transformed the clinical care of advanced kidney cancer. While oncologists consolidate the gains of the wave of new agents, comprising a panoply of anti-vascular endothelial growth factor multi-targeted tyrosine kinase inhibitors...

Full description

Bibliographic Details
Main Authors: Ravindran Kanesvaran, Min-Han Tan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Journal of Carcinogenesis
Subjects:
Online Access:http://www.carcinogenesis.com/article.asp?issn=1477-3163;year=2014;volume=13;issue=1;spage=3;epage=3;aulast=Kanesvaran